Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.320
-0.119 (-4.86%)
May 12, 2025, 4:00 PM - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $205.98 million as of May 12, 2025. Its market cap has increased by 8.06% in one year.
Market Cap
205.98M
Enterprise Value
150.63M
1-Year Change
8.06%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $205.98M, an increase of 64.50%. That is a compound annual growth rate of 4.22%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |